Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quantification Tools for a Novel Tau PET Marker in a Rare Neurological Disease: 18F-PI-2620 in Progressive Supranuclear Palsy

NCT07105384 is registered in ClinicalTrials.gov with Fundacion Clinic per a la Recerca Biomédica as lead sponsor.

NCT NCT07105384
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07105384 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quantification Tools for a Novel Tau PET Marker in a Rare Neurological Disease: 18F-PI-2620 in Progressive Supranuclear Palsy
Lead sponsor
Fundacion Clinic per a la Recerca Biomédica
Phase
Phase 2
Overall status
Active, not recruiting
Start date
February 4, 2025
Completion date
December 20, 2028
Enrollment
66 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease